BWA
TXG icon

Basecamp Wealth Advisors’s 10x Genomics TXG Stock Holding History

Basecamp Wealth Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-62
Closed -$1.01K – 2171
2025
Q4 		$1.01K Buy
+62
New +$937 ﹤0.01% 1494

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Basecamp Wealth Advisors's TXG Position: Q1 2026 in Review

Basecamp Wealth Advisors sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 62 shares — an estimated $1.01K sold.

Basecamp Wealth Advisors first reported a position in TXG in Q4 2025 and held it in 1 quarter. The position peaked at $1.01K in Q4 2025. 330 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Basecamp Wealth Advisors reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
  • Basecamp Wealth Advisors sold 62 10x Genomics shares in Q1 2026, an estimated $1.01K.
  • Basecamp Wealth Advisors first reported a position in 10x Genomics in Q4 2025 and held it in 1 quarter.
  • Basecamp Wealth Advisors's 10x Genomics position peaked at $1.01K in Q4 2025.
  • 330 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q1 2026, filed 24 Jun 2026.